Aims-To increase the sensitivity of an automated chlamydia enzyme immunoassay by significantly lowering its cut off value, and to maintain specificity by confirmation with polymerase chain reaction (PCR) and direct immunofluorescent antibody test (DFA). Methods-Over five months, the cut off value of the enzyme imnmunoassay used to screen urogenital samples for chlamydia antigen was reduced from 80 to 10. Samples with a test value of 10 or above were further tested with a commercial PCR assay. All samples during the first three months and discrepant samples during the last two months of the study were also tested with the DFA. and ligase chain reaction have been proved to be significantly more sensitive than EIA.5 6 Our earlier studies comparing an automated EIA system (VIDAS; Biomerieux, France) using an expanded gold standard including PCR and DFA suggested that the manufacturer's recommended cut off value of the VIDAS was set too high and could be lowered without significant effect on its specificity.7 Using the recommended cut off, the EIA was found to have a sensitivity of 76% with urethral swabs from high risk male patients comparing with the expanded gold standard.7 It was estimated that using VIDAS alone, the rate of underdiagnosis from endocervical swabs was more than 30%. 
confirmation with polymerase chain reaction (PCR) and direct immunofluorescent antibody test (DFA). Methods-Over five months, the cut off value of the enzyme imnmunoassay used to screen urogenital samples for chlamydia antigen was reduced from 80 to 10. Samples with a test value of 10 or above were further tested with a commercial PCR assay. All samples during the first three months and discrepant samples during the last two months of the study were also tested with the DFA. Results-3250 urogenital swabs (1246 urethral, 1335 endocervical, 669 pooled urethrallendocervical) from and ligase chain reaction have been proved to be significantly more sensitive than EIA.5 6 Our earlier studies comparing an automated EIA system (VIDAS; Biomerieux, France) using an expanded gold standard including PCR and DFA suggested that the manufacturer's recommended cut off value of the VIDAS was set too high and could be lowered without significant effect on its specificity. 7 Using the recommended cut off, the EIA was found to have a sensitivity of 76% with urethral swabs from high risk male patients comparing with the expanded gold standard.7 It was estimated that using VIDAS alone, the rate of underdiagnosis from endocervical swabs was more than 30%. The PCR assay was performed within 48 to 72 hours after the EIA. An adapted procedure of specimen preparation was used so that the same specimen prepared for EIA, stored at 4°C, could be used in the PCR assay.9 Briefly, 200 gl of urine resuspension buffer (Roche) was added to 50 ,ul of sample in VIDAS sample treatment reagent after the boiling step and incubated at room temperature for one hour. One millilitre of urine diluent (Roche) was then added and the mixture vortexed and incubated for 10 minutes at room temperature. Amplification of the C trachomatis cryptic plasmid DNA was performed on 50 gl of the prepared sample following the usual Amplicor procedure, and PCR product was detected in the supplied microtitre plates following the manufacturer's instruction. An absorbency reading at 450 nm of 0.5 or above was considered as positive and a reading of between 0.2 and 0.5 as equivocal.
DIRECT IMMUNOFLUORESCENT ANTIBODY
During the first three months of the study, all samples with an EIA reading above the lowered cut off value of 10 were further tested by DFA. During the last two months of the study, only samples with discrepant EIA and PCR results or samples that gave equivocal PCR results were further tested by DFA. Specimen preparation for DFA was similar to that previously described.7 Briefly, residue samples were centrifuged at 12 000 xg for 30 minutes in a microfuge and the pellets were resuspended in 25 id of phosphate buffered saline, air dried and acetone fixed, and stained with the fluorescein labelled monoclonal antibody against C trachomatis major outer membrane protein supplied by the manufacturer. The presence of three or more elementary bodies was taken as a positive result. The quality of each slide was also assessed by recording the presence of epithelial cells. The DFA test was read independently by two microscopists who then agreed on a result without knowledge of the EJA test values.
DEFINITIONS
Samples with EIA test values below 10 were discarded as negative with no further tests. As the sensitivity and specificity of both PCR and DFA have been evaluated previously and found to be satisfactory for EIA confirmation,29 for the purpose of this study, samples with an EIA test value of 10 or above that were found positive by either PCR or DFA were reported as positive. Equivocal PCR results were not considered as positive unless they tested positive by DFA. There were no further attempts to resolve discrepant results because of depletion of samples.
STATISTICAL ANALYSIS
The change in prevalence of detection was analysed using the x2 test. A p value of less than 0.05 was taken as significant. The odds ratio (OR) and the 95% confidence intervals (CI) were calculated in cases of significance. urethrallendocervical swabs, p = 0.255). However, when endocervical swabs were compared with pooled urethral/endocervical swabs, the pooled samples gave a significantly higher yield regardless of whether the confirmation strategy was used (EIA only, p = 0.0002; OR = 2.22; 95% CI = 1.41 to 3.50; revised cut off with confirmation, p << 0.0001, OR = 2.4, 95% CI = 1.58 to 3.64). Apart from the specific change made in the specimen collection policy in female patients, there was no evidence of any change in consultation pattern in the hospital genitourinary medicine clinic during the study period. These results suggested that the inclusion of urethral swabs in addition to endocervical swabs improved the detection of C trachomatis in female patients.
Results
The percentage of confirmed positive samples in relation to the actual EIA test value was studied (table 2) . When the EIA test value was cut off at 20, the overall percentage of confirmation was uniformly 80% or above and the percentages of confirmation in male patients were always 100%. This confirmed that the lack of sensitivity of the EIA test was partly because of the recommended cut off value being set too high. However, when the EIA test value was below 20, the percentage of positive confirmation was reduced to 25%. All five samples that had EIA test values above 20 but not confirmed as positive were from female patients (three endocervical swabs and two pooled urethral/endocervical swabs). When EIA reading was below 20, the percentage of confirmed positive were 26% in men and 24% in women (not significant, p = 0.838).
Discussion
The use of PCR or DFA for confirmation of chlamydia EIA results has been published previously."' Most studies involved the use of a revised cut off value for the EIA.' 3 9 0stergaard et al9 reported the successful use of PCR (Amplicor) and DFA to confirm EIA (MicroTrak EIA) using a revised cut off that was 70% below the recommended value and found a high concordance rate between PCR and DFA (98.2%). Here, we report a successful attempt to reproduce their method using another EIA system (VIDAS). As we have not tested samples that had an EIA reading of less than 10, it was not possible to say whether this approach has identified all the positive samples. However, our previous work using an expanded gold standard on the same patient population showed that EIA underdiagnosed by about one third8 and this is similar to the figure of 33.8% obtained from the present study. Also, the drop in percentage of confirmed positive results from 80% to 25% when the test value was below 20 suggested that the selected revised cut off value was appropriate.
It is of interest that the sample that was EIA positive but both PCR and DFA negative, and four other samples that had high EIA reading but not confirmed as positive, were all from female patients. This highlighted the need of a confirmatory test for female specimens. The role of cross reacting organisms in particular Gram negative bacteria in urogenital tracts of women and children causing false positive EIA has previously been described. 10 11 Although female samples appeared to have the benefit of improved specificity using this confirmatory system, the improvement in yield was highest among male patients in this series. This was probably because male urethral samples had fewer chlamydiae and positivity was underestimated by the less sensitive EIA. The improved sensitivity of the revised cut off with confirmation thus allowed the detection of more positive cases in male specimens compared with female specimens. The inclusion of urethral swabs from female patients also had a significant effect in yield. Detection of C trachomatis in female urethral samples but not in concomitantly taken endocervical swabs has been described. '2 12 During this study, we did not notice any significant difference in the quality of the endocervical smears, as judged by the presence of epithelial cells, to that from pooled urethral/endocervical specimens. Thus, the findings in this study that pooled urethral/ endocervical swabs consistently gave a higher positive yield suggested that in infected females, the urethra may harbour organisms that are sometimes absent or only present in small quantities in the endocervix. It is not necessary in practice to determine the exact anatomical site of infection in most clinical situations, therefore, the use of pooled specimens should be recommended as it is more cost effective than testing swabs separately from different anatomical sites.
Most studies on the laboratory detection of C trachomatis have used more than one diagnostic test and defined true positive by expanded gold standard.7 '5 However, in practice, exhaustive testing of individual samples is not possible. Most diagnostic laboratories rely on a combination of a screening assay plus one or two confirmatory tests. Repeat samples are usually requested when the results remain equivocal. The strategy adopted in this study appears to fit this purpose. EIA is ideal as a screening test but it is neither sensitive nor specific. Lowering of the cut off value may increase non-specificity, boost sensitivity, and allows confirmation by another method with a different principle.
The two confirmatory tests used in this study, however, have their own problems. DFA, ifperformed by experienced technicians is both sensitive and specific.7 16 Some studies comparing DFA and PCR have concluded that DFA could be as sensitive'6 or more so than PCR. '5 However, DFA is a subjective test and performance could be variable dependent on experience. The procedure is labour intensive and clearly not suitable for large volume work.
PCR, on the other hand, can be automated. The Amplicor system has a built-in enzyme (Amperase) that digests amplicons after reaction to prevent PCR product carryover, and gives an objective optical density reading. Amplicor was found in one study9 to be capable of detecting chlamydia organisms at 10-fold higher concentrations than DFA. This may explain the 12 The results from this study suggest that it is possible to use EIA with a significantly lowered cut off as a primary screening test, and use PCR as the second line confirmatory test on the same specimen. DFA, being more labour intensive, could be used as a third test to confirm equivocal PCR results, and on samples that had a relatively high EIA reading but negative by PCR. Assuming a 10% confirmation rate in a laboratory that handles 10 000 specimens a year, 20 specimens will need confirmation per week and this is a suitable batch size for PCR. The overall cost will be significantly lower compared with direct screening of all samples by an amplification method. This strategy may not be the perfect solution to the current problem of underdiagnosis of chlamydia, but should be considered as an interim measure while funding for the use of better tests are sought. As the detection rate using pooled urethral/endocervical swabs was significantly higher than endocervical swabs, the use of pooled specimens in females should be considered. 
